Morphine hydrochloride sustained release - Takeda
Alternative Names: TAK 453 SR; TAK-453Latest Information Update: 11 Jun 2015
At a glance
- Originator Takeda
- Class Morphine derivatives; Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer pain
Most Recent Events
- 11 Jun 2015 No recent reports on development identified - Registered for Cancer pain in Japan (PO)
- 21 Oct 2002 Phase-III clinical trials in Cancer pain management in Japan (PO)
- 18 Apr 2002 Phase-II clinical trials in Pain in Japan (PO)